Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Chinese Patent Office
Medtronic
Citi
Dow
Deloitte
US Army
Express Scripts
Mallinckrodt
AstraZeneca

Generated: January 20, 2018

DrugPatentWatch Database Preview

HYDROCHLOROTHIAZIDE; SPIRONOLACTONE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for hydrochlorothiazide; spironolactone and what is the scope of hydrochlorothiazide; spironolactone patent protection?

Hydrochlorothiazide; spironolactone
is the generic ingredient in three branded drugs marketed by Gd Searle Llc, Ascot, Mutual Pharm, Mylan, Purepac Pharm, Sandoz, Sun Pharm Industries, Superpharm, Watson Labs, Ivax Pharms, Lederle, Parke Davis, Upsher Smith, Usl Pharma, and Vangard, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-one drug master file entries for hydrochlorothiazide; spironolactone. Seven suppliers are listed for this compound.
Summary for HYDROCHLOROTHIAZIDE; SPIRONOLACTONE
Pharmacology for HYDROCHLOROTHIAZIDE; SPIRONOLACTONE
Ingredient-typeThiazides
Drug ClassAldosterone Antagonist
Thiazide Diuretic
Mechanism of ActionAldosterone Antagonists
Physiological EffectIncreased Diuresis

US Patents and Regulatory Information for HYDROCHLOROTHIAZIDE; SPIRONOLACTONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; spironolactone TABLET;ORAL 087398-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Industries SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; spironolactone TABLET;ORAL 089534-001 Jul 2, 1987 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ascot SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; spironolactone TABLET;ORAL 088025-001 Nov 23, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lederle SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE hydrochlorothiazide; spironolactone TABLET;ORAL 087511-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Purepac Pharm SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE hydrochlorothiazide; spironolactone TABLET;ORAL 088054-001 Aug 18, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; spironolactone TABLET;ORAL 086881-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Upsher Smith SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE hydrochlorothiazide; spironolactone TABLET;ORAL 087553-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Gd Searle Llc ALDACTAZIDE hydrochlorothiazide; spironolactone TABLET;ORAL 012616-005 Dec 30, 1982 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Purepac Pharm SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; spironolactone TABLET;ORAL 087999-001 Nov 6, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Vangard SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE hydrochlorothiazide; spironolactone TABLET;ORAL 087655-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Julphar
Argus Health
Boehringer Ingelheim
Chinese Patent Office
Daiichi Sankyo
Dow
Healthtrust
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot